CLINICAL_TRIALS
trial_result
· 2010-02-19
Clinical Trial Update: Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer [Phase 1]
Summary
Phase 1 safety study of XL999 in adults with non-small cell lung cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Symphony Evolution, Inc. | Conditions: Non-Small-Cell Lung Cancer | Phase 1 | Status: TERMINATED